Subscribe
istock-588592670_uschools
uschools / iStockphoto.com
4 October 2017Americas

House of Representatives committee probes Allergan IPR deal

A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Congress sets date for hearing on Allergan-tribe deal
6 November 2017   A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity.
Americas
Tribe ‘outraged’ at bill seeking to revoke IPR immunity
6 October 2017   The Saint Regis Mohawk Tribe has said it is “outraged” by proposed legislation introduced by Senator Claire McCaskill aimed at tackling sovereign immunity.
Americas
Is the Allergan patent deal a misuse of sovereign immunity?
19 September 2017   Earlier this month, in a bid to obtain immunity against an inter partes review (IPR), Allergan transferred its patent rights for a dry eye treatment to a Native American tribe.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Congress sets date for hearing on Allergan-tribe deal
6 November 2017   A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity.
Americas
Tribe ‘outraged’ at bill seeking to revoke IPR immunity
6 October 2017   The Saint Regis Mohawk Tribe has said it is “outraged” by proposed legislation introduced by Senator Claire McCaskill aimed at tackling sovereign immunity.
Americas
Is the Allergan patent deal a misuse of sovereign immunity?
19 September 2017   Earlier this month, in a bid to obtain immunity against an inter partes review (IPR), Allergan transferred its patent rights for a dry eye treatment to a Native American tribe.

More on this story

Americas
Congress sets date for hearing on Allergan-tribe deal
6 November 2017   A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity.
Americas
Tribe ‘outraged’ at bill seeking to revoke IPR immunity
6 October 2017   The Saint Regis Mohawk Tribe has said it is “outraged” by proposed legislation introduced by Senator Claire McCaskill aimed at tackling sovereign immunity.
Americas
Is the Allergan patent deal a misuse of sovereign immunity?
19 September 2017   Earlier this month, in a bid to obtain immunity against an inter partes review (IPR), Allergan transferred its patent rights for a dry eye treatment to a Native American tribe.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB